Peter H Wiernik - JoVE Visualize

Showing results (51-60 of 128) with videos related to

Pageof 13

Sort By:

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004

Clonal isolation of different strains of mouse mammary tumor virus-like DNA sequences from both the breast tumors and non-Hodgkin's lymphomas of individual patients diagnosed with both malignanciesPolly R Etkind, Alexandre F R Stewart, Thambi Dorai, et al.

Leukemia & Lymphoma|October 30, 2004

Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphomaDoru T Alexandrescu, Janice P Dutcher, Kevin O'Boyle, et al.

American Journal of Hematology|December 21, 2004

Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three casesLydia Koulova, Doru Alexandrescu, Janice P Dutcher, et al.

Medical Oncology (Northwood, London, England)|August 20, 2005

Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-Hodgkin's lymphomaJoseph A Sparano, Abdissa Negassa, Erick Lansigan, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010

Phase II study of interleukin-4 in indolent B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E5Y92)Peter H Wiernik, Janice P Dutcher, Xiapan Yao, et al.

Leukemia & Lymphoma|October 21, 2003

A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486)Peter H Wiernik, Peter A Cassileth, Traci Leong, et al.

American Journal of Therapeutics|November 1, 1996

Phase II Trial of Paclitaxel in Patients with Advanced Colon Cancer Previously Untreated with Cytotoxic Chemotherapy: An Eastern Cooperative Oncology Group Trial (PA286)Avi I. Einzig, Donna Neuberg, Peter H. Wiernik, et al.

Medical Oncology (Northwood, London, England)|January 29, 2010

Detection of a new embryonic antigen (ESA-10) in the blood of patients with cancer: preliminary results in the United StatesPeter H Wiernik, Dahlia Elkadi, Alvaro Luongo-Cespedes, et al.

American Journal of Clinical Oncology|August 7, 2003

Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphomaHuda Salman, Alejandra Perez, Joseph A Sparano, et al.

Cancer|July 15, 2010

Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology GroupJacob M Rowe, Haesook T Kim, Peter A Cassileth, et al.

Pageof 13

Showing results (51-60 of 128) with videos related to

Sort By:

Pageof 13

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004

Clonal isolation of different strains of mouse mammary tumor virus-like DNA sequences from both the breast tumors and non-Hodgkin's lymphomas of individual patients diagnosed with both malignanciesPolly R Etkind, Alexandre F R Stewart, Thambi Dorai, et al.

Leukemia & Lymphoma|October 30, 2004

Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphomaDoru T Alexandrescu, Janice P Dutcher, Kevin O'Boyle, et al.

American Journal of Hematology|December 21, 2004

Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three casesLydia Koulova, Doru Alexandrescu, Janice P Dutcher, et al.

Medical Oncology (Northwood, London, England)|August 20, 2005

Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-Hodgkin's lymphomaJoseph A Sparano, Abdissa Negassa, Erick Lansigan, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010

Phase II study of interleukin-4 in indolent B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E5Y92)Peter H Wiernik, Janice P Dutcher, Xiapan Yao, et al.

Leukemia & Lymphoma|October 21, 2003

A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486)Peter H Wiernik, Peter A Cassileth, Traci Leong, et al.

American Journal of Therapeutics|November 1, 1996

Phase II Trial of Paclitaxel in Patients with Advanced Colon Cancer Previously Untreated with Cytotoxic Chemotherapy: An Eastern Cooperative Oncology Group Trial (PA286)Avi I. Einzig, Donna Neuberg, Peter H. Wiernik, et al.

Medical Oncology (Northwood, London, England)|January 29, 2010

Detection of a new embryonic antigen (ESA-10) in the blood of patients with cancer: preliminary results in the United StatesPeter H Wiernik, Dahlia Elkadi, Alvaro Luongo-Cespedes, et al.

American Journal of Clinical Oncology|August 7, 2003

Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphomaHuda Salman, Alejandra Perez, Joseph A Sparano, et al.

Cancer|July 15, 2010

Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology GroupJacob M Rowe, Haesook T Kim, Peter A Cassileth, et al.

Pageof 13